Pfizer Faces UPC Case In 2nd IP Battle Over COVID-19 Pill
Pfizer is facing a patent infringement claim in Europe over its blockbuster Paxlovid COVID-19 treatment, marking its second court battle against Enanta Pharmaceuticals after the biotech firm's copycat claims failed to...To view the full article, register now.
Already a subscriber? Click here to view full article